Elite Pharmaceuticals, Inc. (ELTP)
OTCMKTS
· Delayed Price · Currency is USD
0.550
-0.020 (-3.51%)
Dec 20, 2024, 4:00 PM EST
Elite Pharmaceuticals Revenue
Elite Pharmaceuticals had revenue of $18.88M in the quarter ending September 30, 2024, with 33.36% growth. This brings the company's revenue in the last twelve months to $71.17M, up 73.45% year-over-year. In the fiscal year ending March 31, 2024, Elite Pharmaceuticals had annual revenue of $56.63M with 65.79% growth.
Revenue (ttm)
71.17M
Revenue Growth
+73.45%
P/S Ratio
8.05
Revenue / Employee
1.11M
Employees
64
Market Cap
587.18M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2024 | 56.63M | 22.47M | 65.79% |
| Mar 31, 2023 | 34.16M | 1.89M | 5.87% |
| Mar 31, 2022 | 32.26M | 6.88M | 27.11% |
| Mar 31, 2021 | 25.38M | 7.39M | 41.05% |
| Mar 31, 2020 | 17.99M | 10.43M | 137.76% |
| Mar 31, 2019 | Pro | Pro | Pro |
| Mar 31, 2018 | Pro | Pro | Pro |
| Mar 31, 2017 | Pro | Pro | Pro |
| Mar 31, 2016 | Pro | Pro | Pro |
| Mar 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Sandoz Group AG | 10.11B |
| Telix Pharmaceuticals Limited | 430.80M |
| Elekta AB (publ) | 1.66B |
| Ryman Healthcare Limited | 458.44M |
| Verano Holdings Corp. | 897.57M |
| Vireo Growth Inc. | 98.53M |
| Medexus Pharmaceuticals Inc. | 104.76M |
Elite Pharmaceuticals News
- 20 days ago - Elite Pharmaceuticals Announces Commercial Launch of Acetaminophen and Hydrocodone Tablets - Newsfile Corp
- 4 weeks ago - Elite Pharmaceuticals Inc (ELTP) Q2 2025 Earnings Call Highlights: Strong Revenue Growth and ... - GuruFocus
- 4 weeks ago - Elite Pharmaceuticals receives FDA approval on its NDA for ADHD treatment - Seeking Alpha
- 4 weeks ago - Q2 2025 Elite Pharmaceuticals Inc Earnings Call Transcript - GuruFocus
- 4 weeks ago - Elite Pharmaceuticals Receives FDA Approval for Generic Vyvanse - Newsfile Corp
- 5 weeks ago - Elite Pharmaceuticals, Inc. (ELTP) Q2 2025 Earnings Conference Call Transcript - Seeking Alpha
- 5 weeks ago - Elite Pharmaceuticals Inc Reports $18.9 Million Revenue and $3. ... - GuruFocus
- 5 weeks ago - Elite Pharmaceuticals, Inc. Reports Financial Results for the Second Quarter of Fiscal Year 2025 Ended September 30, 2024 and Provides Conference Call Information - Newsfile Corp